This e-alert is part of a series of e-alerts summarizing publicly available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of prescription drugs, medical devices, and biologics.
Covington Alert: FDA Advertising and Promotion Enforcement Activities: Update
Apr 01, 2021
March 9, 2021
Posted by Covington and Burling LLP